Airway wall remodelling: Does it occur and what does it mean?

Clinical and Experimental Allergy

Volumn 29, Issue 11, 1999, Pages 1457-1466

  Kips, J C ^a   Pauwels, R A ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CELL ADHESION MOLECULE; COLLAGEN; CYTOKINE; ENDOTHELIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GLYCOSAMINOGLYCAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; INTEGRIN; LEUKOTRIENE; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; SOMATOMEDIN; STEROID; TENASCIN; TERBUTALINE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TYROSINE KINASE RECEPTOR; UNINDEXED DRUG;

AIRWAY; ASTHMA; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; LUNG;

EID: 0032734013     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00659.x     Document Type: Review

References (135)

1. 1 Takizawa T, Thurlbeck WM. Muscle and mucous gland size in the major bronchi of patients with chronic bronchitis, asthma and asthmatic bronchitis. Am Rev Respir Dis 1971; 104:331-6.
2. 2 Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; ii:520-4.
3. 3 Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997; 27:363-71.
4. 4 Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140:1745-53.
5. 5 Laitinen A, Altraja A, Kämpe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997; 156:951-8.
6. 6 Brewster CEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990; 3: 507-11.
7. 7 Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969; 24:176-9.
8. 8 Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156:229-33.
9. 9 Kuwano K, Bosken CH, Paré PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1220-5.
10. 10 Ebina M, Yaegashi H, Chiba R, Takahashi T, Motomiya M, Tanemura M. Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. Am Rev Respir Dis 1990; 141:1327-32.
11. 11 Thomson RJ, Bramley AM, Schellenberg RR. Airway muscle stereology: implications for increased shortening in asthma. Am J Respir Crit Care Med 1996; 154:749-57.
12. 12 Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. Am Rev Respir Dis 1993; 148:720-6.
13. 13 Vignola AM, Chanez P, Campbell AM et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998; 157:403-9.
14. 14 Phunek P, Roche WR, Turzikora J, Kurdmann J, Warner JA. Eosinophilic inflammation in the bronchial mucosa of children with bronchial asthma. Eur Respir J 1997; 10 (Suppl. 25): 160s.
15. 15 Chakir J, Laviolette M, Boutet M, Laliberté R, Dubé J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996; 75:735-44.
16. 16 Carroll N, Elliott J, Morton A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147:405-10.
17. 17 Paganin F, Séneterre E, Chanez P et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996; 153:110-4.
18. 18 Awadh N, Müller NL, Park CS, Abboud RT, FitzGerald JM. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 1998; 53:248-53.
19. 19 Boulet LP, Bélanger M, Carrier G. Airway responsiveness and bronchial wall thickness in asthma with or without fixed airflow obstruction. Am J Respir Crit Care Med 1995; 152:865-71.
20. 20 Okazawa M, Müller N, McNamara AE, Child S, Verburgt L, Paré PD. Human airway narrowing measured using high resolution computed tomography. Am J Respir Crit Care Med 1996; 154:1557-62.
21. 21 Post GR, Brown JH. G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 1996; 10:741-9.
22. 22 Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Ann Rev Biochem 1993; 62:453-81.
23. 23 Hirst J, Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. Eur Respir J 1996; 9:808-20.
24. 24 Panettieri RA, Yadvish PA, Kelly AM, Rubinstein NA, Kotlikoff MI. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol 1990; 259:L365-71.
25. 4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol 1995; 269:L151-7.
26. 26 Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 1996; 156:275-83.
27. 27 McKay S, de Jongste JC, Saxena PD, Sharma HS. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-β1. Am J Respir Cell Mol Biol 1998; 18:823-33.
28. 28 Glassberg MK, Ergul KA, Wanner A, Puett D. Endothelin-1 promotes mitogenesis in airway smooth muscle cells. Am J Respir Cell Mol Biol 1994; 10:316-21.
29. 29 Rogalsky V, Den Todorov GT, Ohnuma T. Increase in protein kinase C activity is associated with human fibroblast growth inhibition. FEBS Lett 1992; 304:153-6.
30. 30 Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cell stimulated via the FceRI. Role for mast cell-derived transforming growth factor-β and tumor necrosis factor-α. J Exp Med 1994; 180: 2027-37.
31. 31 Stewart AG, Tomlinson PR, Fernandes DJ, Wilson JW, Harris T. Tumor necrosis factor-α modulates mitogenic responses of human cultured airway smooth muscle. Am J Respir Cell Mol Biol 1995; 12:110-9.
32. 32 De S, Zelazny ET, Souhrada JF, Souhrada M. Interleukin-1β stimulates the proliferation of cultured airway smooth muscle cells via platelet-derived growth factor. Am J Respir Cell Mol Biol 1993; 9:645-51.
33. 33 Doucet C, Brouty-Boyé D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. J Clin Invest 1998, 101:2129-39.
34. 34 Massagué J. The transforming growth factor-β family. Ann Rev Cell Biol 1990; 6:597-641.
35. 35 Black PN, Young PG, Skinner SJM. Response of airway smooth muscle cells to TGF-β1: effects on growth and synthesis of glycosaminoglycans. Am J Physiol 1996; 271:L910-7.
36. 36 Reddy KB, Howe PH. Transforming growth factor β1-mediated inhibition of smooth muscle: proliferation is associated with a late G1 cell cycle arrest. J Cell Physiol 1993; 156:48-55.
37. 37 Cohen MD, Ciocca V, Panettieri RA. TGF-β1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am J Respir Cell Mol Biol 1997; 16:85-90.
38. 38 Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261:4337-45.
39. 39 Fine A, Goldstein RH. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 1987; 262:3897-902.
40. 40 Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovector-mediated gene transfer of active Transforming Growth Factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100:768-76.
41. 41 Romberger DJ, Beckmann JD, Claassen L, Ertl RF, Rennard SI. Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-β. Am J Respir Cell Mol Biol 1992; 7:149-55.
42. 42 Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90:1-7.
43. 43 Maniscalco WM, Campbell MH. Transforming growth faclor-β induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells. Am J Physiol 1994; 266:L672-80.
44. 44 Edwards DR, Murphy G, Reynolds JJ, Whitlam SE, Dochterty AJP, Angel P. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6:389-403.
45. 45 Vignola AM, Chanez P, Chiappara G et al. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156:591-9.
46. 46 Minshall EM, Leung DYM, Martin RJ et al. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997; 17:326-33.
47. 47 Ohno I, Nitta Y, Yamauchi K et al. Transforming growth factor β1 (TGFβ1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1996; 15:404-9.
48. 48 Hirst SJ, Barnes PJ, Twort CHC. Quantifying proliferation in cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am J Respir Cell Mol Biol 1992; 7:574-81.
49. 49 Kovacs EJ, Dipietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994; 8:854-61.
50. 50 Stewart CEH, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996; 76:1005-26.
51. 51 Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990; 265:7709-12.
52. 52 Cerutis DR, Nogami M, Anderson JL et al. Lysophophatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells. Am J Physiol 1997; 273:L10-L15.
53. 53 Kim JS, McKinnis VS, Nawrocki A, White SR. Stimulation of migration and wound repair of guinea-pig airway epithelial cells in response to Epidermal Growth Factor. Am J Respir Cell Mol Biol 1998; 18:66-74.
54. 54 Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Makino S. detection of transforming growth factor-β in sputum from patients with bronchial asthma by eosinophil survival assay and enzyme-linked immunosorbent assay. Clin Exp Allergy 1996; 26:557-62.
55. 55 Redington AE, Madden J, Frew AJ et al. Transforming growth factor-β1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156:642-7.
56. 56 Vignola AM, Chanez P, Chiappara G et al. Release of transforming growth factor-beta (TGF-β) and fibronectin by alveolar macrophages in airway diseases. Clin Exp Immunol 1996; 106:114-9.
57. 57 Hoshino M, Nakamura Y, Sim JJ et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF) -1 expression in bronchial asthma, Clin Exp Allergy 1998; 28:568-77.
58. 58 Amishima M, Munakata M, Nasuhara Y et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am J Respir Crit Care Med 1998; 157:1907-12.
59. 59 Onno I, Nitta Y, Yamauchi K et al. Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am J Respir Cell Mol Biol 1995; 13:639-47.
60. 60 Chanez P, Vignola M, Stenger R, Vic P, Michel FB, Bousquet J. Platelet-derived growth factor in asthma. Allergy 1995; 50:878-83.
61. 61 Taylor IK, Sorooshian M, Wangoo A et al. Platelet-derived growth factor-β mRNA in human alveolar macrophages in vivo in asthma. Eur Respir J 1994; 7:1966-72.
62. 62 Aubert JD, Hayashi S, Hards J, Bai TR, Paré PD, Hogg JC. Platelet-derived growth factor and its receptor in lungs from patients with asthma and chronic airflow limitation. Am J Physiol 1994; 266:L655-63.
63. 63 Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC. Transforming growth factor β1 gene expression in human airways. Thorax 1994; 49:225-32.
64. 64 Magnan A, Retornaz F, Tsicopoulos A et al. Altered compartmentalization of transforming growth factor-β in asthmatic airways. Clin Exp Allergy 1997; 27:389-95.
65. 65 Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax 1998; 53:21-7.
66. 66 Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 1998; 53:129-36.
67. 67 Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992; 7:120-5.
68. 68 Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5:2145-54.
69. 69 Ohno I, Ohtani H, Nitta Y et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997; 16:212-9.
70. 70 Hoshino M, Nakamura Y, Sim JJ, Shimojo J. Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998; 102:783-8.
71. 71 Vignola AM, Riccobono L, Mirabella A et al. Sputum metalloproteinase-9/Tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic-bronchitis. Am J Respir Crit Care Med 1998; 158:1945-50.
72. 72 Vignola AM, Bonanno A, Mirabella A et al. Increased levels of elastase and α1 -antitrypsin in sputum of asthmatic patients. Am J Respir Crit Care Med 1998; 157:505-11.
73. 73 Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64:867-9.
74. 74 Raghow R. The role of extracellular matrix in post-inflammatory wound healing and fibrosis. FASEB J 1994; 8:823-31.
75. 75 Spurzem JR. Function at the junction: dynamic interactions between lung cells and extracellular matrix. Thorax 1996; 51:956-8.
76. 76 Roman J. Extracellular matrix and lung inflammation. Immunol Res 1996; 15:163-78.
77. 77 Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61:1303-13.
78. 78 Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990; 172: 69-75.
79. 79 Degrendele HC, Estess P, Picker LJ, Siegelman MH. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med 1996; 183:1119-30.
80. 80 Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6:2397-404.
81. 81 Lavens SE, Goldring K, Thomas LH, Warner JA. Effects of integrin clustering on human lung mast cells and basophils. Am J Respir Cell Mol Biol 1996; 14:95-103.
82. 82 Anwar ARE, Walsh GM, Cromwell O, Kay AB, Wardlaw AJ. Adhesion to fibronectin prolongs eosinophil survival. J Exp Med 1993; 177:839-43.
83. 83 Neeley SP, Hamann KJ, Dowling TL, Mcallister KT, White SR, Leff AR. Augmentation of stimulated eosinophil degranulation by VLA-4 (CD49d) -mediated adhesion to fibronectin. Am J Respir Cell Mol Biol 1994; 11:206-13.
84. 84 Tourkin A, Anderson T, Leroy EC, Hoffman S. Eosinophil adhesion and maturation is modulated by laminin. Cell Adhesion Commun 1993; 1:161-76.
85. 85 Prescott SL, Macaubas C, Holt BJ et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T-cell responses towards the Th2 cytokine profile. J Immunol 1998; 160:4730-7.
86. 86 Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994; 12:991-1045.
87. 87 Holgate ST. The cellular and mediator basis of asthma in relation to natural history. Lancet 1997; 350 (Suppl. II):5-9.
88. 88 Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
89. 89 Gizycki MJ, Ädelroth E, Rogers AV, O'Byrne PM, Jeffery PK. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am J Respir Cell Mol Biol 1997; 16:664-73.
90. 90 Scannell C, Chen L, Aris RM et al. Greater ozone-induced inflammatory responses in subjects with asthma. Am J Respir Crit Care Med 1996; 154:24-9.
91. 91 Tang W, Geba GP, Zheng T et al. Targeted expression of 1L-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling and airways obstruction. J Clin Invest 1996; 98:2845-53.
92. 92 Sterk PJ, Bel EH. The shape of the dose-response curve to inhaled bronchoconstrictor agents in asthma and COPD. Am Rev Respir Dis 1991; 143:1433-7.
93. 93 Woolcock AJ, Salome CM, Yan K. The shape of the dose response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130:71-5.
94. 94 Moreno RH, Hogg JC, Paré PD. Mechanics of airway narrowing. Am Rev Respir Dis 1986; 133:1171-80.
95. 95 James AL, Paré PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989; 139:242-6.
96. 96 Wiggs BR, Hrousis CA, Drazen JM, Kamm RD. On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol 1997; 83:1814-21.
97. 97 Lambert RK, Wiggs BR, Kuwano K, Hogg JC, Paré PD. Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 1993; 74:2771-81.
98. 98 Macklem PT. A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. Am J Respir Crit Care Med 1996; 153:83-9.
99. 99 Sullivan P, Stephens D, Ansari T, Costello J, Jeffery P. Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J 1998; 12:811-5.
100. 100 Lötvall J, Inman M, O'Byrne P. Measurement of airway hyperresponsiveness: new considerations. Thorax 1998; 53:419-24.
101. 101 Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997; 111:852-7.
102. 102 Brown RH, Zerhouni EA, Mitzner W. Airway edema potentiates airway reactivity. J Appl Physiol 1995; 79:1242-8.
103. 103 Palmans E, Kips JC, Pauwels RA. The effect of chronic-allergen exposure on airway structure and responsiveness in rats. Am J Respir Crit Care Med 1998; 157:A822.
104. 104 Lambert RK, Codd SL, Alley MR, Pack RJ. Physical determinants of bronchial mucosal folding. J Appl Physiol 1994; 77:1206-16.
105. 105 Bramley AM, Roberts CR, Schellenberg RR. Collagenase increases shortening of human bronchial smooth muscle in vitro. Am J Respir Crit Care Med 1995; 152:1513-7.
106. 106 Meiss RA. The influence of intercellular connective tissue on smooth muscle shortening. Biophys J 1997; 72:A277.
107. 107 Halayko AJ, Ma X, Stephens NL. Markers of airway smooth muscle phenotype. Am J Physiol 1996; 270:L1040-L1051.
108. 108 Solway J, Fredberg JJ. Perhaps airway smooth muscle dysfunction contributes to asthmatic bronchial hyperresponsiveness after all. Am J Respir Cell Mol Biol 1997; 17:144-6.
109. 109 Fredberg JJ, Jones KA, Nathan M et al. Friction in airway smooth muscle: mechanism, latch and implications in asthma. J Appl Physiol 1996; 81:2703-12.
110. 110 Mitchel RW, Leff AR, Magnussen H, Rabe KR. Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity. Am J Physiol 1994; 267:L218-22.
111. 111 Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995, 96:2393-403.
112. 112 Wilson JW, Li X, Pain MCF. The lack of distensibility of asthmatic airways. Am Rev Respir Dis 1993; 148:806-9.
113. 113 Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70:171-9.
114. 114 Lange P, Pamer J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-200.
115. 115 Ulrik CS, Lange P, Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150:629-34.
116. 116 Panhuysen CIM, Vonk JM, Koëter GH et al. Adult patients may outgrow their asthma. Am J Respir Crit Care Med 1997; 155:1267-72.
117. 117 Young PG, Skinner SJM, Black PN. Effects of glucocorticoids and β-adrenoceptor agonists on the proliferation of airway smooth muscle. Eur J Pharmacol 1995; 273: 137-43.
118. 118 Tomlinson PR, Wilson JW, Stewart AG. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol 1995; 49:1809-19.
119. 119 Jeffery PK, Godfrey RW, Ädelroth E, Nelson F, Rogers A, Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992; 145:890-9.
120. 120 Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide and a β2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomised, double-blind, parallel group controlled study. J Allergy Clin Immunol 1992; 90:32-42.
121. 121 Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med 1998; 157:s1-s53.
122. 122 Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in non steroid-dependent asthmatics. Am Rev Respir Dis 1990; 142:832-6.
123. 123 van-Essen-Zandvliet EE, Hughes MD, Waalkens HJ et al. Effects of 22 months treatment with inhaled corticosteroids and/or beta2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992; 146:547-54.
124. 124 Haahtela T, Järvinen M, Kava T et al. Comparison of a β2-agonist, terbutaline, with an inhaled conicosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325:388-92.
125. 125 Bel EH, Timmers MC, Zwinderman AH, Dijkman JH, Sterk PJ. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects. Am Rev Respir Dis 1991; 143:109-13.
126. 126 Overbeek SE, Rijnbeek PR, Vons C, Mulder PGH, Hoogsteden HC, Bogaard JM. Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics. Eur Respir J 1996; 9:2256-62.
127. 127 Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. Long-term effects of a long-acting β2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992; 327:1198-203.
128. 128 Lundgren R, Söderberg M, Hörstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988; 1:883-9.
129. 129 Trigg CJ, Manolitsas ND, Wang J et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994; 150:17-22.
130. 130 Olivieri D, Chetta A, del Donno M et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma. Am J Respir Crit Care Mod 1997; 155:1864-71.
131. 131 Sont JK, Willems LNA, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999; 159:1043-51.
132. 132 Warshamana GS, Martinez S, Lasky JA, Corti M, Brody AR. Dexamethasone activates expression of the PDGF-α receptor and induces lung fibroblast proliferation. Am J Physiol 1998; 274:L499-507.
133. 133 Haahtela T, Järvinen M, Kava T et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331:700-5.
134. 134 Selroos O, Pietinalho A, Lüfroos A, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995; 108:1228-34.
135. 135 Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88:373-81.